COVID-19 antibody treatment clinical trial paused over potential safety concern


Drugmaker Eli Lilly announced a temporary hold on its COVID-19 antibody therapy. The pause comes as a need for the treatment grows. A CDC report found that a 13-year-old girl infected 11 members of her family while on vacation. Adriana Diaz reports.

Source link

Leave A Reply

Your email address will not be published.